Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Calidi Biotherapeutics, Inc. (CLDI) had Weighted-Average Shares Outstanding (Diluted) of 0.67M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-23.81M |
|
-- |
|
-- |
|
$21.78M |
|
$-21.78M |
|
$-0.42M |
|
$-22.20M |
|
$-22.20M |
|
$-22.21M |
|
$-22.21M |
|
$-22.21M |
|
$-22.21M |
|
$-21.78M |
|
$-20.20M |
|
0.67M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.67M |
$-35.65 |
|
$-35.65 |
|
| Balance Sheet Financials | |
$10.23M |
|
$0.87M |
|
$3.96M |
|
$14.18M |
|
$9.50M |
|
$0.74M |
|
$2.72M |
|
$12.21M |
|
$1.97M |
|
$1.97M |
|
$1.97M |
|
1.73M |
|
| Cash Flow Statement Financials | |
$-19.69M |
|
$-0.02M |
|
$27.36M |
|
$2.17M |
|
$9.81M |
|
$7.64M |
|
$2.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.08 |
|
-- |
|
-- |
|
0.27 |
|
2.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1128.50% |
|
-1128.51% |
|
-156.60% |
|
-818.61% |
|
$1.14 |
|
$-29.56 |
|
$-29.53 |
|